Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
S&P Indices and the Indexing Business in 2012
Viceira, Luis M.; Wagonfeld, Alison BerkleyCaso HBS-213049-EFinanzasIn June 2012, Standard & Poor's Indices is finalizing a deal with the CME Group, the largest global exchange for futures and options and majority owner of Dow Jones Indexes, to combine their respective indices business into a new joint venture called S&P Dow Jones Indices. This case discusses the index provider business model through the lenses of this transaction: sources of revenue and profitability, business valuation, uses of indexes in the m...Desde 8,20 €
-
COVID-19 Management at Vall d'Hebron University Hospital (Abridged)
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, Miguel; Esquerdo, Mariona; Arnal, LaiaCaso P-1192-EInnovación y cambio, Servicios y operacionesThe case describes the changes that occurred at the Vall d'Hebron University Hospital, the largest tertiary hospital in Barcelona, during the beginning of the COVID-19 pandemic, when it had to be transformed into an infectious disease hospital dedicated to the coronavirus in record time and with the same staff as before. The manager of the center reflected on the preparation for the pandemic, the arrival of the first COVID patients, the scaling u...Desde 8,20 €
-
Hospital Universitari Vall d'Hebron: gestión de la COVID-19
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, MiguelCaso P-1188Innovación y cambio, Servicios y operacionesEl caso describe los cambios que se produjeron en el Hospital Universitari Vall d'Hebron, el mayor hospital terciario en Barcelona, durante la pandemia de la COVID-19, cuando tuvo que transformarse en un hospital de enfermedades infeccionas dedicado al coronavirus en un tiempo récord, manteniendo el mismo personal. El director gerente del centro reflexiona sobre la preparación para la pandemia, la llegada de los primeros pacientes COVID, el escal...Desde 8,20 €
-
Hospital Universitari Vall d'Hebron: gestión de la COVID-19 (abreviado)
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, Miguel; Esquerdo, Mariona; Arnal, LaiaCaso P-1192Innovación y cambio, Servicios y operacionesEl caso describe los cambios que se produjeron en el Hospital Universitari Vall d'Hebron, el mayor hospital terciario en Barcelona, durante la pandemia de la COVID-19, cuando tuvo que transformarse en un hospital de enfermedades infeccionas dedicado al coronavirus en un tiempo récord, manteniendo el mismo personal. El director gerente del centro reflexiona sobre la preparación para la pandemia, la llegada de los primeros pacientes COVID, el escal...Desde 8,20 €
-
Warner Bros. Entertainment
Pisano, Gary P.; Wagonfeld, Alison BerkleyCaso HBS-610036-EServicios y operacionesExamines the process used by a major motion picture studio to develop and select movie projects. Warner Bros.' strategy is to focus its efforts on a small number of major "event" films (i.e., films with the potential to generate gross box-office receipts of $300 million or more). This strategy--which has worked for the past two years--entails risks. The studio is now asking how it can better manage these risks and, specifically, how it can improv...Desde 8,20 €
-
Dividend Policy at Linear Technology (Spanish version)
Baker, Malcolm P.; Wagonfeld, Alison BerkleyCaso HBS-209S19FinanzasIn 1992, Linear Technology, a designer and manufacturer of analog semiconductors, initiated a dividend. The firm increased its dividend by approximately $0.01 per share each year thereafter. In fiscal year 2002, Linear experienced its first significant drop in sales since its 1986 initial public offering. Sales dropped by 47%, and profits fell by 54%. In the spring of 2003, CFO Paul Coghlan is deciding whether to recommend yet another increase in...Desde 8,20 €
-
Amyris Biotechnologies: Commercializing Biofuel
Pisano, Gary P.; Wagonfeld, Alison BerkleyCaso HBS-610031-EServicios y operacionesIn 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the research and development team and the operations group were building processes that could accommodate both as well. CEO John Melo hoped to have commercial product available in 2011...Desde 8,20 €